Visalytics
Visalytics
approved EB-2 (NIW)

Engineer II

Chemical Engineering · China · 2022-06-07

Processing Time
519 days
Decision Date
2022-06-07
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate downstream process development for biotherapeutic drugs using innovative purification methods. The work focuses on increasing drug purity and yield to improve access to vital and affordable medications while reducing the financial burden of medical care.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the high cost of healthcare and medical debt in the U.S. by promoting affordable drug production processes.

2 Well-positioned to Advance the Endeavor Met

The petitioner's background, including a Master's degree and a cited publication record, renders him uniquely capable of completing the research.

3 Waiver Benefit Met

On balance, the petitioner's work in mitigating the costliest aspects of drug production justifies a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Master of Science in chemical engineering and a record of 3 peer-reviewed journal articles with 86 citations. The case was supported by 4 expert recommendation letters and evidence of research funding from the NSF, NSFC, and Tianjin Natural Science Foundation, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Research Scientist

Research and Development · Taiwan

WeGreened EB-2 (NIW) approved
Indiana 552 days 2025-04-26
The petitioner proposes to develop advanced bioanalytical chemistry techniques to improve molecular characterization and expedite the drug discovery process. His work focuses on investigating biological processes driving neurodegenerative disorders, metabolic diseases, and cancer to facilitate new therapies. Additionally, he aims to enhance quality control measures within pharmaceutical manufacturing.
View Case

Associate Professor

Biotechnology · Sudan

WeGreened EB-2 (NIW) approved
22 days 2023-08-01
The petitioner proposes to utilize biotechnological research techniques paired with molecular, pharmacological, and microbiological methods to discover novel drugs for the treatment of non-communicable diseases such as cancer and Alzheimer’s disease. This work focuses on enhancing drug efficacy and efficiency to develop therapeutics that reverse symptoms and alleviate healthcare and economic burdens.
View Case

Postdoctoral Researcher

Chemicals · India

WeGreened EB-2 (NIW) approved
Massachusetts 156 days 2022-10-04
The petitioner proposes to continue research on developing state-of-the-art drug delivery approaches that cross biological interfaces. This work focuses on enabling the facile treatment of a wide range of disorders, including neurological disorders, metastatic cancer, and COVID-19, through protein-based therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Chemicals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-06-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 519 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist